About HIV Treatment Bulletin
HTB is a community publication that critically reports on advances in HIV research. Founded April 2000.
The publications is primarily produced for health workers and activists as it reviews the most important advances related to the clinical management of HIV and access to treatment.
HTB is now distributed in electronic format: online, by email and in RSS and in PDF format. The printed edition was discontinued in 2018 to reflect the changes in how information is needed.
As a technical bulletin, estimated readership is 5,000 doctors and other health professionals in the UK and internationally. Approximately 5% of readers are activists and/or advocates who are people living with HIV.
Editor: Simon Collins
Proofreading and social media:
Ashwin Caffery
ISSN 1472-4863
Subscriptions are free
HTB is distributed by email alert, RSS feed and on the web.
Medical review board
HTB is supported by comments from a medical review board.
Dr Adrian Bamford, Great Ormond Street Hospital.
Dr Tristan Barber, Royal Free Hospital, London.
Dr Karen Beckerman, Albert Einstein College of Medicine, NYC.
Dr Sanjay Bhagani, Royal Free Hospital, London.
Dr Julie Fox, Kings College London.
Richard Jefferys, TAG, New York.
Professor Saye Khoo, University of Liverpool Hospital.
Dr Stefan Mauss, Düsseldorf.
Professor Caroline Sabin, UCL Medical School, London.
Dr Graham P Taylor, Imperial College, London.
Dr Stephen Taylor, Birmingham Heartlands Hospital.
Dr Laura Waters, Mortimer Market Clinic, London.
In addition to the support provided by our medical and community review boards, i-Base work closely with a range of other organisations.
Related publications
- HTB South – Focus on southern Africa
- HIV Tedavi Bülteni (HTB Turkey) – Produced in Turkey
- HIV Bilten (HTB West Balkans) – Published in Bosnian, Montenegrin, Croatian and Serbian.
- ARV4IDUs – HIV treatment and IDUs
Editorial policy, copyright and funding
Comments to articles are compiled from consultant, author and editorial responses.
Some articles are reproduced from other respected sources and copyright for these articles remains with the original authors and sources, as indicated at the end of each article.
We thank those organisations for recognising the importance of providing widely distributed free access to information both to people living with HIV and to the healthcare professionals involved in their care. We also thank them for permission to distribute their excellent work and we encourage htb readers to visit the source websites for further access to their coverage of HIV treatment.
Articles written and credited to i-Base writers, as with all i-Base originated material, remains the copyright of HIV i-Base, but these articles may be reproduced by community and not-for-profit organisations without individual written permission and reproduction is encouraged. A credit and link to the original author, the HTB issue and the i-Base website is always appreciated.
HIV i-Base receives unconditional educational grants from charitable trusts, individual donors and pharmaceutical companies. All editorial policies are strictly independent of funding sources.
Last updated: 5 June 2026.